![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 11, 2015 1:26:19 PM
1. Milestones on track.
2. Technology
3. Market potential of s speculative stock.
4. Cash, burn rate and further potential dilution.
I hate but appreciate the tight lipped approach. Although ISRG is "not concerned", I am sure they have a keen eye on Titan's technology and progress. We in the biotech arena are constantly spying, "researching" competition. With each milestone met the pressure builds. It's quite possible we go it alone, but more likely an acquisition is in the cards. Either a deep pocket biotech looking to enter robotic surgery or the cash cow ISRG pays big to round out their current offerings.
Not sure, but appreciate the recent update.
Question for those here: if necessary, when might there be a need for future cash raise, i.e. Dilution. Break it down!
Thanks!!!
Largest holding long and strong! Fingers crossed....
Glidelogic Corp. Announces Revolutionary AI-Generated Content Copyright Protection Solution • GDLG • Jul 26, 2024 12:30 PM
Southern Silver Files NI43-101 Technical Report for its Updated Preliminary Economic Assessment for the Cerro Las Minitas Project • SSV • Jul 25, 2024 8:00 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM